Medtronic has received European regulatory approval for the Achieve electrophysiology mapping catheter used for assessment of pulmonary vein isolation when treating paroxysmal atrial fibrillation. The device is used in conjunction with Medtronic’s Arctic Front cryoablation system.
The Achieve Mapping Catheter has a distal mapping section with a circular loop which is available in two loop diameters (15 mm and 20 mm). It is deployed through the Arctic Front guidewire lumen, allowing for a single transseptal puncture. The catheter features eight evenly spaced electrodes on a loop, enabling physicians to map electrical conduction between the left atrium and pulmonary veins. Additionally, the catheter allows for assessment of pulmonary vein potentials both before and after cryoablation and also helps physicians assess time-to-effect during cryoablation.
Features from the product page:
•3.3 Fr, 1.1 mm (0.043″) catheter shaft size
•165 cm in total length; 146 cm in usable length
•Two loop sizes available: 15 mm and 20 mm
•Two electrode spacings: 4 mm and 6 mm
•Eight 1 mm electrodes
•Catheter is compatible with minimum ID of 3.8 Fr, 1.3 mm (0.049″)
Product page: Achieve Mapping Catheter…
Press release: Medtronic Announces European Launch of Achieve™ Mapping Catheter…
